News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,521 Results
Type
Article (1924)
Company Profile (2)
Press Release (71595)
Section
Business (25333)
Career Advice (9)
Deals (4555)
Drug Development (8158)
FDA (1806)
Job Trends (799)
News (37023)
Policy (3564)
Tag
2027 BioCapital Standard (1)
Academia (98)
Accelerated approval (5)
ADA (2)
Allergies (21)
Alliances (8166)
ALS (16)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (120)
Approvals (1973)
Artificial intelligence (36)
ASCO (37)
Autoimmune disease (38)
Automation (2)
Bankruptcy (8)
Best Places to Work (584)
BIO (9)
Biosimilars (95)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (64)
Cancer (657)
Cardiovascular disease (26)
Career advice (9)
CAR-T (16)
CDC (1)
Cell therapy (61)
Cervical cancer (5)
Clinical research (7711)
Collaboration (348)
Commercialization (2)
Compensation (27)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (100)
Cystic fibrosis (8)
Data (862)
Depression (17)
Dermatology (11)
Diabetes (44)
Diagnostics (647)
Digital health (7)
Drug discovery (44)
Drug pricing (1)
Duchenne muscular dystrophy (46)
Earnings (8211)
Events (7611)
Executive appointments (78)
FDA (2331)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (159)
Gene editing (7)
Generative AI (1)
Gene therapy (41)
GLP-1 (82)
Government (240)
Grass and pollen (1)
Guidances (40)
Healthcare (1093)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (26)
Immunology and inflammation (7)
Immuno-oncology (11)
Indications (30)
Infectious disease (226)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (42)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (953)
Licensing (1)
Liver cancer (19)
Longevity (3)
Lung cancer (119)
Lymphoma (56)
Machine learning (1)
Manufacturing (133)
Marketing (4)
MASH (19)
Medical device (1171)
Medtech (1190)
Mergers & acquisitions (3120)
Metabolic disorders (113)
mRNA (7)
Multiple sclerosis (25)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (343)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (38)
Opinion (1)
Ovarian cancer (35)
Pain (20)
Pancreatic cancer (31)
Parkinson's disease (50)
Partnered (4)
Patents (77)
Patient recruitment (84)
Peanut (1)
People (5195)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2083)
Phase 2 (3269)
Phase 3 (2904)
Pipeline (1276)
Policy (1)
Postmarket research (241)
Preclinical (710)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (26)
Rare diseases (88)
Real estate (606)
Regulatory (3070)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (21)
Series A (33)
Series B (24)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (424)
Stomach cancer (2)
Supply chain (13)
Vaccines (46)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (6)
Last 7 days (55)
Last 30 days (223)
Last 365 days (2829)
2026 (1760)
2025 (2684)
2024 (3254)
2023 (3815)
2022 (7003)
2021 (6371)
2020 (5870)
2019 (3857)
2018 (3013)
2017 (3561)
2016 (3172)
2015 (4029)
2014 (3021)
2013 (2602)
2012 (2775)
2011 (2902)
2010 (2666)
Location
Africa (88)
Alabama (4)
Arizona (14)
Arkansas (1)
Asia (22311)
Australia (2487)
California (822)
Canada (475)
China (521)
Colorado (5)
Connecticut (25)
Delaware (8)
Europe (13473)
Florida (88)
Georgia (18)
Hawaii (1)
Illinois (45)
India (55)
Indiana (27)
Japan (350)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (129)
Massachusetts (664)
Michigan (9)
Minnesota (38)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (1)
New Jersey (503)
New York (289)
North Carolina (126)
Northern California (350)
Ohio (6)
Oregon (1)
Pennsylvania (155)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (404)
Tennessee (4)
Texas (62)
United States (3161)
Utah (30)
Vermont (1)
Virginia (61)
Washington D.C. (3)
Washington State (61)
Wisconsin (8)
73,521 Results for "biolinerx ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Business
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx Ltd. reported its unaudited financial results for the first quarter ended March 31, 2024, and provided recent corporate and portfolio updates.
May 28, 2024
·
17 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
August 6, 2026
·
16 min read
Business
BioLineRx to Report 2023 Annual Financial Results on March 26, 2024
BioLineRx Ltd. today announced it will release its audited financial results for the year ended December 31, 2023 on Tuesday, March 26, 2024, before the U.S. markets open.
March 20, 2024
·
1 min read
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification - May 17, 2024
BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, announced that it has received a notification letter from the Nasdaq Stock Market LLC.
May 17, 2024
·
6 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Business
BioLineRx to Report First Quarter 2024 Results on May 28, 2024
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the quarter ended March 31, 2024 on Tuesday, May 28, 2024, before the U.S. markets open.
May 22, 2024
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options - July 1, 2026
July 1, 2026
·
5 min read
Business
BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx Ltd., a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, reported its financial results for the year ended December 31, 2023, and provided recent corporate and portfolio updates.
March 26, 2024
·
19 min read
1 of 7,353
Next
